Given the multiple genetic alterations that are present in pancreatic cancer and the minimal physiological effect conferred by the re-expression of miR-129-2 in pancreatic cancer cell lines in vitro, more than one mechanism may contribute to over-expression of SOX4 in pancreatic cancers. The gene discussed is SOX4; the disease is familial pancreatic carcinoma.